Phathom Pharmaceuticals I... (PHAT)
6.74
-0.05 (-0.74%)
At close: Jan 15, 2025, 9:43 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 682.00K | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 167.00K | 620.00K | 521.00K | 300.00K | 8.00K | n/a |
| Gross Profit | 515.00K | -620.00K | -521.00K | -300.00K | -8.00K | n/a |
| Operating Income | -167.31M | -172.44M | -135.08M | -125.67M | -106.22M | -1.23M |
| Interest Income | 7.88M | 2.13M | 41.00K | 1.09M | 1.09M | n/a |
| Pretax Income | -201.59M | -197.72M | -143.88M | -129.07M | -255.13M | -1.29M |
| Net Income | -201.59M | -223.01M | -148.09M | -133.32M | -209.74M | -1.29M |
| Selling & General & Admin | 117.93M | 101.00M | 62.74M | 27.52M | 6.94M | 1.21M |
| Research & Development | 49.90M | 71.44M | 72.34M | 98.15M | 99.27M | 20.00K |
| Other Expenses | n/a | -110.00K | -2.06M | -8.00K | -49.56M | -50.00K |
| Operating Expenses | 167.83M | 172.44M | 135.08M | 125.67M | 106.22M | 1.23M |
| Interest Expense | 41.97M | 27.30M | 6.79M | 4.58M | 4.18M | 13.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 167.99M | 172.44M | 135.08M | 125.67M | 106.22M | 1.23M |
| Income Tax | n/a | 25.28M | 4.21M | 4.25M | -45.39M | 13.00K |
| Shares Outstanding (Basic) | 51.29M | 39.12M | 37.00M | 33.23M | 24.73M | 8.58M |
| Shares Outstanding (Diluted) | 51.29M | 39.12M | 37.00M | 33.23M | 24.73M | 8.58M |
| EPS (Basic) | -3.93 | -5.7 | -4 | -4.01 | -8.48 | -0.15 |
| EPS (Diluted) | -3.93 | -5.7 | -4 | -4.01 | -8.48 | -0.15 |
| EBITDA | -159.05M | -171.82M | -134.56M | -124.19M | -250.95M | -50.00K |
| Depreciation & Amortization | 575.00K | 620.00K | 521.00K | 300.00K | 8.00K | 1.23M |